BR112018016420A2 - opioid and device combination products with enhanced safety and efficacy profiles - Google Patents

opioid and device combination products with enhanced safety and efficacy profiles

Info

Publication number
BR112018016420A2
BR112018016420A2 BR112018016420A BR112018016420A BR112018016420A2 BR 112018016420 A2 BR112018016420 A2 BR 112018016420A2 BR 112018016420 A BR112018016420 A BR 112018016420A BR 112018016420 A BR112018016420 A BR 112018016420A BR 112018016420 A2 BR112018016420 A2 BR 112018016420A2
Authority
BR
Brazil
Prior art keywords
opioid
self
drug
prescription
overdose
Prior art date
Application number
BR112018016420A
Other languages
Portuguese (pt)
Inventor
L Valentine Edmund
Original Assignee
L Valentine Edmund
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/US2016/046491 external-priority patent/WO2017027673A1/en
Application filed by L Valentine Edmund filed Critical L Valentine Edmund
Publication of BR112018016420A2 publication Critical patent/BR112018016420A2/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/14—Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
    • A61M5/168—Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters ; Monitoring media flow to the body
    • A61M5/172—Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters ; Monitoring media flow to the body electrical or electronic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/14—Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
    • A61M5/142—Pressure infusion, e.g. using pumps
    • A61M5/14244—Pressure infusion, e.g. using pumps adapted to be carried by the patient, e.g. portable on the body
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/14—Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
    • A61M5/168—Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters ; Monitoring media flow to the body
    • A61M5/172—Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters ; Monitoring media flow to the body electrical or electronic
    • A61M5/1723—Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters ; Monitoring media flow to the body electrical or electronic using feedback of body parameters, e.g. blood-sugar, pressure
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H20/00—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance
    • G16H20/10—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients
    • G16H20/13—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients delivered from dispensers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B2503/00—Evaluating a particular growth phase or type of persons or animals
    • A61B2503/08—Elderly
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B3/00—Apparatus for testing the eyes; Instruments for examining the eyes
    • A61B3/10—Objective types, i.e. instruments for examining the eyes independent of the patients' perceptions or reactions
    • A61B3/11—Objective types, i.e. instruments for examining the eyes independent of the patients' perceptions or reactions for measuring interpupillary distance or diameter of pupils
    • A61B3/112—Objective types, i.e. instruments for examining the eyes independent of the patients' perceptions or reactions for measuring interpupillary distance or diameter of pupils for measuring diameter of pupils
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/117—Identification of persons
    • A61B5/1171—Identification of persons based on the shapes or appearances of their bodies or parts thereof
    • A61B5/1172—Identification of persons based on the shapes or appearances of their bodies or parts thereof using fingerprinting
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
    • A61B5/1455—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue using optical sensors, e.g. spectral photometrical oximeters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/24—Detecting, measuring or recording bioelectric or biomagnetic signals of the body or parts thereof
    • A61B5/316—Modalities, i.e. specific diagnostic methods
    • A61B5/318—Heart-related electrical modalities, e.g. electrocardiography [ECG]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/48—Other medical applications
    • A61B5/4833—Assessment of subject's compliance to treatment
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/68—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient
    • A61B5/6801—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient specially adapted to be attached to or worn on the body surface
    • A61B5/6802—Sensor mounted on worn items
    • A61B5/681—Wristwatch-type devices
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/68—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient
    • A61B5/6887—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient mounted on external non-worn devices, e.g. non-medical devices
    • A61B5/6898—Portable consumer electronic devices, e.g. music players, telephones, tablet computers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00—General characteristics of the apparatus
    • A61M2205/18—General characteristics of the apparatus with alarm
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00—General characteristics of the apparatus
    • A61M2205/35—Communication
    • A61M2205/3576—Communication with non implanted data transmission devices, e.g. using external transmitter or receiver
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00—General characteristics of the apparatus
    • A61M2205/35—Communication
    • A61M2205/3576—Communication with non implanted data transmission devices, e.g. using external transmitter or receiver
    • A61M2205/3584—Communication with non implanted data transmission devices, e.g. using external transmitter or receiver using modem, internet or bluetooth
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00—General characteristics of the apparatus
    • A61M2205/50—General characteristics of the apparatus with microprocessors or computers
    • A61M2205/502—User interfaces, e.g. screens or keyboards
    • A61M2205/505—Touch-screens; Virtual keyboard or keypads; Virtual buttons; Soft keys; Mouse touches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00—General characteristics of the apparatus
    • A61M2205/60—General characteristics of the apparatus with identification means
    • A61M2205/609—Biometric patient identification means

Abstract

a presente invenção refere-se a um sistema de administração de opioide oral compreendido de um aplicativo específico para opioide móvel que utiliza um algoritmo de administração de fármaco específico de paciente e fármaco que incorpora o uso de informação/valores de autoavaliação, autoteste e/ou autorrelato, prescrição e dispositivo de administração digitalmente capturados para: (i) controlar administração de opioide para aperfeiçoar a segurança da medicação; (ii) personalizar a terapia de fármaco oral; (iii) aperfeiçoar a eficácia da medicação enquanto evita efeitos colaterais mediados por fármaco, (iv) diminuir uso indevido, abuso, dosagem excessiva, dosagem menor, dependência, vício, divergência, ingestão acidental, overdose e mortes, (v) aperfeiçoar o tratamento da doença, (vi) assegurar obediência à prescrição e (vii) promover persistência da prescrição em uma base em tempo real de custo eficaz.The present invention relates to an oral opioid delivery system comprised of a mobile opioid-specific application that utilizes a patient and drug-specific drug delivery algorithm that incorporates the use of self-assessment, self-test and / or self-assessment information / values. digitally captured self-report, prescription and delivery device to: (i) control opioid administration to improve medication safety; (ii) customize oral drug therapy; (iii) improve medication effectiveness while avoiding drug-mediated side effects, (iv) decrease misuse, abuse, overdose, lower dosage, dependence, addiction, divergence, accidental ingestion, overdose, and deaths; (v) improve treatment (vi) ensure compliance with the prescription and (vii) promote prescription persistence on a cost effective real time basis.

BR112018016420A 2016-02-12 2017-02-13 opioid and device combination products with enhanced safety and efficacy profiles BR112018016420A2 (en)

Applications Claiming Priority (12)

Application Number Priority Date Filing Date Title
US201662294585P 2016-02-12 2016-02-12
US201662325012P 2016-04-20 2016-04-20
PCT/US2016/046491 WO2017027673A1 (en) 2015-08-11 2016-08-11 Devices, system and method to control the delivery of oral medications
US201662375256P 2016-08-15 2016-08-15
US201662375192P 2016-08-15 2016-08-15
US201662416972P 2016-11-03 2016-11-03
US201662427919P 2016-11-30 2016-11-30
US201662432394P 2016-12-09 2016-12-09
US201662432358P 2016-12-09 2016-12-09
US201662432248P 2016-12-09 2016-12-09
US201662432292P 2016-12-09 2016-12-09
PCT/US2017/017665 WO2017139761A1 (en) 2016-02-12 2017-02-13 Opioid+device combination products with improved safety and efficacy profiles

Publications (1)

Publication Number Publication Date
BR112018016420A2 true BR112018016420A2 (en) 2018-12-26

Family

ID=59563464

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112018016420A BR112018016420A2 (en) 2016-02-12 2017-02-13 opioid and device combination products with enhanced safety and efficacy profiles

Country Status (8)

Country Link
EP (1) EP3413781A4 (en)
JP (1) JP2019513504A (en)
CN (1) CN109068974A (en)
AU (1) AU2017218008A1 (en)
BR (1) BR112018016420A2 (en)
CA (1) CA3014319A1 (en)
MX (1) MX2018009776A (en)
WO (1) WO2017139761A1 (en)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11282597B2 (en) 2015-03-27 2022-03-22 Protenus Inc. Methods and systems for analyzing accessing of drug dispensing systems
WO2018039562A1 (en) 2016-08-25 2018-03-01 Validose, Inc. System and method for controlled medical therapy
WO2018204921A1 (en) * 2017-05-05 2018-11-08 QuantaEd, LLC Systems, methods, and structures for medication adherence
WO2018236865A1 (en) 2017-06-20 2018-12-27 Addinex Technologies, Inc. Prescription drug abuse prevention system
CA3072427C (en) 2017-08-08 2023-12-05 Fresenius Medical Care Holdings, Inc. Systems and methods for treating and estimating progression of chronic kidney disease
FR3072821B1 (en) * 2017-10-19 2022-11-04 Medissimo PROCEDURE FOR COMPLIANCE BY PREPARING THE DOSES TO BE ADMINISTERED OF MEDICINES
US10831911B2 (en) 2017-12-19 2020-11-10 Industrial Technology Research Institute Method, computer program product and processing system for generating secure alternative representation
US11627919B2 (en) 2018-06-06 2023-04-18 Masimo Corporation Opioid overdose monitoring
US20200098460A1 (en) * 2018-09-26 2020-03-26 EPIS Holding Company, LLC Systems and methods for identifying individual doses of medication
BR112021006548A2 (en) * 2018-10-09 2021-07-06 Inovytec Medical Solutions Ltd system for immediate personalized treatment of a patient in a medical emergency
US11464410B2 (en) 2018-10-12 2022-10-11 Masimo Corporation Medical systems and methods
CN109447830A (en) * 2018-10-31 2019-03-08 南京德益康信息科技有限公司 A method of it is issued for controlling drug
US20200143925A1 (en) * 2018-11-05 2020-05-07 Timothy Earl King Forensic system and method for detecting fraud, abuse, and diversion in the prescriptive use of controlled substances
US10909261B2 (en) 2018-12-12 2021-02-02 Industrial Technology Research Institute Method and computer program product for generating secure alternative representation for numerical datum
CN110151184A (en) * 2019-04-19 2019-08-23 昆明依利科特科技有限公司 Contactless drug addict's rapid detection system and method
JP7255359B2 (en) * 2019-05-29 2023-04-11 コニカミノルタ株式会社 Program, Information Notification Apparatus, and Computer Implemented Method for Posting Information
CA3140861A1 (en) * 2019-06-10 2020-12-17 Nicholas T. Culberton Methods and systems for analyzing accessing of drug dispensing systems
CN110378130B (en) * 2019-06-18 2023-09-19 佛山市第一人民医院（中山大学附属佛山医院） Role-based access control method and device for milbezoar medicine prescription
US20210290177A1 (en) 2020-03-20 2021-09-23 Masimo Corporation Wearable device for monitoring health status
JP7423815B2 (en) 2020-10-20 2024-01-29 セトラスホールディングス株式会社 Clinical trial management device, clinical trial management method, clinical trial management program, and clinical trial management system
CN114667964B (en) * 2020-12-24 2023-11-14 中国科学院脑科学与智能技术卓越创新中心 Method for evaluating addiction of non-human primate medicaments and application thereof
CN113197782A (en) * 2021-05-20 2021-08-03 新疆维吾尔自治区人民医院 Multifunctional intelligent reminding medicine box

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020024633A1 (en) * 1999-04-09 2002-02-28 Daehoon Kim Pupil evaluation system
CN1771881A (en) * 2005-11-10 2006-05-17 昆明依利科特科技有限公司 Quick identification method of the addication and dependance of opium drug addict
US8357114B2 (en) * 2006-01-06 2013-01-22 Acelrx Pharmaceuticals, Inc. Drug dispensing device with flexible push rod
US20070260491A1 (en) * 2006-05-08 2007-11-08 Pamela Palmer System for delivery and monitoring of administration of controlled substances
US9542847B2 (en) * 2011-02-16 2017-01-10 Toyota Motor Engineering & Manufacturing North America, Inc. Lane departure warning/assistance method and system having a threshold adjusted based on driver impairment determination using pupil size and driving patterns
EP2731574B1 (en) * 2011-07-13 2017-03-15 White Cell RX Holdings Pty Ltd Medication management system
US9361431B2 (en) * 2012-04-03 2016-06-07 Gen-9, Inc. Methods and systems to secure control and enhance medication adherence
US9579457B2 (en) * 2013-03-15 2017-02-28 Flint Hills Scientific, L.L.C. Method, apparatus and system for automatic treatment of pain
EP2799009A1 (en) * 2013-04-29 2014-11-05 Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. Non-invasive method for prediction of opioid-analgesia and opioid-blood-concentrations
US9980642B2 (en) * 2013-09-19 2018-05-29 Children's National Medical Center Apparatus and method for determining physiologic perturbations of a patient
US10289806B2 (en) * 2013-11-14 2019-05-14 Elwha Llc Devices, systems, and methods for automated medical product or service delivery
EP3136948B1 (en) * 2014-04-29 2022-06-08 Dignity Health Systems and methods for non-intrusive drug impairment detection
CN107106006A (en) * 2014-08-04 2017-08-29 纽约大学 For diagnosing, evaluating or quantifying medicine use, drug abuse and anesthesia, internuclear ophthalmoplegia, attention deficit hyperactivity disorder (ADHD), chronic traumatic encephalopathic, schizophrenia pedigree obstacle and the method and kit of alcohol consumption
US9357918B1 (en) * 2014-12-18 2016-06-07 Karen Elise Cohen System and method for drug screening and monitoring pupil reactivity and voluntary and involuntary eye muscle function

Also Published As

Publication number Publication date
EP3413781A4 (en) 2020-01-15
JP2019513504A (en) 2019-05-30
EP3413781A1 (en) 2018-12-19
MX2018009776A (en) 2018-11-09
WO2017139761A1 (en) 2017-08-17
AU2017218008A1 (en) 2018-10-04
CN109068974A (en) 2018-12-21
CA3014319A1 (en) 2017-08-17

Similar Documents

Publication Publication Date Title
BR112018016420A2 (en) opioid and device combination products with enhanced safety and efficacy profiles
MX2018013503A (en) Apparatuses, methods, and systems for delivering medication using medication kits.
BR112018077021A2 (en) combination therapies
BR112019003753A2 (en) system and method for controlled medical therapy
BR112014018924A8 (en) METHOD OF GENERATING A CUSTOM DOSAGE LABEL FOR A DRUG DELIVERY DEVICE
NZ769954A (en) Syringe devices for use in an emergency
MX2016008138A (en) System for the transdermal delivery of active ingredient.
AR089862A1 (en) USE OF LAQUINIMOD FOR THE TREATMENT OF PATIENTS WITH CROHN'S DISEASE IN THOSE WHO FAILS AN ANTI-FACTOR THUMOR NECROSIS THERAPY a (ANTI-TNFa) FIRST LINE
BR112018010063A2 (en) porous structures for extended release drug delivery devices
Goudra et al. SEDASYS, sedation, and the unknown
Bossi et al. The vicious circle of treatment-induced toxicities in locally advanced head and neck cancer and the impact on treatment intensity
CY1113488T1 (en) A MEDICINE FOR TWO STAGES PERIODICALLY OPERATIVE THERAPY TREATMENT
MX2015016418A (en) Dihydroetorphine for the provision of pain relief and anaesthesia.
BR112015011294A2 (en) biodegradable and biocompatible plga polymer nanoparticles loaded with the human drug pentoxifylline
AR096223A1 (en) NICOTINE PILL FOR ORAL ADMINISTRATION
BR112022018163A2 (en) DRUG FOR TREATMENT AND/OR PREVENTION OF CANCER, AGENTS THAT INCREASE THE DRUG EFFECTIVENESS OF A PHARMACEUTICAL COMPOSITION AND METHOD FOR TREATMENT AND/OR PREVENTION OF CANCER
BR112022018171A2 (en) MEDICINE FOR THE TREATMENT AND/OR PREVENTION OF CANCER, AGENTS ENHANCEMENT THE DRUG EFFECTIVENESS OF A PHARMACEUTICAL COMPOSITION AND METHOD TO TREAT AND/OR PREVENT CANCER
BR112017022984A2 (en) device for facilitating the positioning of a catheter to deliver a drug to a spontaneously breathing patient
BR112021023354A2 (en) PHARMACEUTICAL METHODS AND COMPOSITIONS TO TREAT DRUG OVERDOSE
Green et al. General approach to and summary of the guideline for the management of atopic dermatitis: CME-summary
BR112019001808A2 (en) anticancer pharmaceutical composition
Johnson Codeine-the facts
Stanciu et al. Opioid Overdoses and Naloxone: What Everyone Needs to Know
Nouibi et al. Self-Medication of a Cancer Patient with Cresol
MX2018003349A (en) Nasal drug products and methods of their use.

Legal Events

Date Code Title Description
B350 Update of information on the portal [chapter 15.35 patent gazette]
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 5A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2658 DE 14-12-2021 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.